Carbapenem-resistant enterobacteriaceae infection Clinical Trials

Delta Trials indexes 19 clinical trials for Carbapenem-resistant enterobacteriaceae infection in its publicly accessible dataset. Of these, 7 enrolling participants at this time and 6 trials have reached completion. This research takes place spanning 66 research sites around the world. An additional 6 trials are in preparatory or other active non-recruiting stages. Since 2020, 3 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.